Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Tarsus Pharmaceuticals

Biotech & Life Sciences · Irvine, United States · Founded 2017 · IPO 2020 Unicorn

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$2.27B
Market cap · Apr/2026
Revenue
$451M
Latest reported FY

Investors

4 investors on Tarsus Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Global footprint

Where Tarsus Pharmaceuticals has talent and traffic

Web traffic by country
38K monthly visits
across markets
🇺🇸 United States92.1%
🇨🇦 Canada6.3%
🇮🇳 India1.1%
🇬🇧 United Kingdom0.8%
🇯🇵 Japan0.3%
Top 5 markets shown

Patent intelligence

$8M patent portfolio · 4 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with topic prominence vs same-sector peers.

Estimated portfolio value
$8M
0.36% of market cap · 20.1× smaller than top peer Amicus Therapeutics ($164M)
4 active patent families
Where Tarsus Pharmaceuticals innovates PharmacologyOptometryBlepharitisPharmaceutical medicineDisease

Tech-focus vs peers

Where Tarsus Pharmaceuticals concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Tarsus Pharmaceuticals and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Tarsus Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.